{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T20:50:50Z","timestamp":1794084650216,"version":"4.8.0"},"reference-count":373,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204633"],"award-info":[{"award-number":["82204633"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2024NSFSC2112"],"award-info":[{"award-number":["2024NSFSC2112"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2026NSFSC0627"],"award-info":[{"award-number":["2026NSFSC0627"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jconrel.2026.114915","type":"journal-article","created":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:08:30Z","timestamp":1775840910000},"page":"114915","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Nanomedicine for colorectal cancer therapy by remodeling the immune microenvironment"],"prefix":"10.1016","volume":"394","author":[{"given":"Yuxin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meiqing","family":"Shui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanrong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaipei","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2026.114915_bb0005","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2026.114915_bb0010","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.cgh.2024.11.019","article-title":"Global distribution of colorectal cancer staging at diagnosis: An evidence synthesis","volume":"23","author":"Guo","year":"2024","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0015","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/jcsm.13158","article-title":"Deep learning-based assessment of body composition and liver tumour burden for survival modelling in advanced colorectal cancer","volume":"14","author":"Keyl","year":"2023","journal-title":"J. Cachexia. Sarcopenia Muscle"},{"key":"10.1016\/j.jconrel.2026.114915_bb0020","first-page":"205","article-title":"Current status of multiple markers in precision immunotherapy for colorectal cancer, cancer","volume":"22","author":"Liu","year":"2025","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2026.114915_bb0025","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41392-024-01953-7","article-title":"Signaling pathways involved in colorectal cancer: pathogenesis and targeted therapy","volume":"9","author":"Li","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114915_bb0030","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.cgh.2025.06.035","article-title":"Advancing inflammatory bowel disease-driven colorectal cancer management: molecular insights and endoscopic breakthroughs towards precision medicine","volume":"23","author":"Iacucci","year":"2025","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s13045-022-01294-4","article-title":"Exploring immunotherapy in colorectal cancer","volume":"15","author":"Weng","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0040","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1186\/s12951-022-01586-4","article-title":"Mechanisms of chemotherapeutic resistance and the application of targeted nanoparticles for enhanced chemotherapy in colorectal cancer","volume":"20","author":"Guo","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0045","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.semcancer.2022.06.002","article-title":"Chemokines and chemokine receptors in colorectal cancer; multifarious roles and clinical impact","volume":"86","author":"Braoudaki","year":"2022","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0050","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1097\/SLA.0000000000006463","article-title":"Circulating metabolic markers identify patients at risk for tumor recurrence: a prospective cohort study in colorectal cancer surgery","volume":"280","author":"Montcus\u00ed","year":"2024","journal-title":"Ann. Surg."},{"key":"10.1016\/j.jconrel.2026.114915_bb0055","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1002\/cac2.12639","article-title":"The Chinese Society of Clinical Oncology (CSCO): clinical guidelines for the diagnosis and treatment of colorectal cancer, 2024 update","volume":"45","author":"Wang","year":"2025","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jconrel.2026.114915_bb0060","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41575-024-00934-z","article-title":"Mechanisms of metastatic colorectal cancer","volume":"21","author":"Ca\u00f1ellas-Socias","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2019.107447","article-title":"5-fluorouracil and other fluoropyrimidines in colorectal cancer: past, present and future","volume":"206","author":"Vodenkova","year":"2020","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.jconrel.2026.114915_bb0070","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s10555-023-10158-3","article-title":"Colorectal cancer: a comprehensive review of carcinogenesis, diagnosis, and novel strategies for classified treatments","volume":"43","author":"Abedizadeh","year":"2024","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb0075","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1039\/D2CC06212G","article-title":"Colorectal cancer therapy mediated by nanomedicines","volume":"59","author":"Zhang","year":"2023","journal-title":"Chem. Commun."},{"key":"10.1016\/j.jconrel.2026.114915_bb0080","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12943-025-02357-z","article-title":"Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery","volume":"24","author":"Sabit","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0085","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.3390\/cancers14163972","article-title":"Recent advances and challenges in cancer immunotherapy","volume":"14","author":"Peterson","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2026.114915_bb0090","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.trecan.2024.05.001","article-title":"Advancements in combining targeted therapy and immunotherapy for colorectal cancer","volume":"10","author":"Singh","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0095","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ctrv.2019.04.003","article-title":"Immunotherapy of colorectal cancer: challenges for therapeutic efficacy","volume":"76","author":"Ciardiello","year":"2019","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb0100","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.annonc.2024.11.012","article-title":"Pembrolizumab versus chemotherapy in microsatellite instability-high or mismatch repair-deficient metastatic colorectal cancer: 5-year follow-up from the randomized phase III KEYNOTE-177 study","volume":"36","author":"Andr\u00e9","year":"2025","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0105","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/d41573-024-00026-2","article-title":"The colorectal cancer drug market","volume":"23","author":"Garc\u00eda","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114915_bb0110","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/S0140-6736(24)02848-4","article-title":"Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial","volume":"405","author":"Andr\u00e9","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.jconrel.2026.114915_bb0115","doi-asserted-by":"crossref","first-page":"1403533","DOI":"10.3389\/fimmu.2024.1403533","article-title":"Immune checkpoint inhibitors in colorectal cancer: limitation and challenges","volume":"15","author":"Yan","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2025.118014","article-title":"Combination therapy with immune checkpoint inhibitors in colorectal cancer: challenges, resistance mechanisms, and the role of microbiota","volume":"186","author":"Rahimi","year":"2025","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jconrel.2026.114915_bb0125","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1038\/s41568-025-00872-1","article-title":"The immune microenvironment of colorectal cancer","volume":"25","author":"Kennel","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0130","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ccell.2024.12.008","article-title":"A constitutive interferon-high immunophenotype defines response to immunotherapy in colorectal cancer","volume":"43","author":"Acha-Sagredo","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.114915_bb0135","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41577-021-00534-x","article-title":"The inflammatory pathogenesis of colorectal cancer","volume":"21","author":"Schmitt","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0140","doi-asserted-by":"crossref","first-page":"1453630","DOI":"10.3389\/fcell.2024.1453630","article-title":"New insight in immunotherapy and combine therapy in colorectal cancer","volume":"12","author":"Ji","year":"2025","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0145","doi-asserted-by":"crossref","first-page":"10259","DOI":"10.1038\/s41467-024-54710-3","article-title":"Spatially organized tumor-stroma boundary determines the efficacy of immunotherapy in colorectal cancer patients","volume":"15","author":"Feng","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114915_bb0150","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/j.apsb.2024.05.032","article-title":"Enhancing cancer immunotherapy: nanotechnology-mediated immunotherapy overcoming immunosuppression","volume":"14","author":"Chen","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114915_bb0155","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jconrel.2023.02.016","article-title":"Nanotechnology for next-generation cancer immunotherapy: state of the art and future perspectives","volume":"356","author":"Chen","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114915_bb0160","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jconrel.2023.09.014","article-title":"Nano-enabled colorectal cancer therapy","volume":"362","author":"Pan","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114915_bb0165","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13045-024-01535-8","article-title":"Nanoparticles in tumor microenvironment remodeling and cancer immunotherapy","volume":"17","author":"Lu","year":"2024","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0170","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.gastro.2019.06.048","article-title":"Influence of the gut microbiome, diet, and environment on risk of colorectal cancer","volume":"158","author":"Song","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jconrel.2026.114915_bb0175","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.tim.2022.08.010","article-title":"Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer","volume":"31","author":"Wang","year":"2023","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.gpb.2022.07.002","article-title":"Gut microbiome in colorectal cancer: clinical diagnosis and treatment","volume":"21","author":"Liu","year":"2023","journal-title":"Genom. Proteom. Bioinf."},{"key":"10.1016\/j.jconrel.2026.114915_bb0185","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccell.2019.02.008","article-title":"KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer","volume":"35","author":"Liao","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.114915_bb0190","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.19025","article-title":"Microsatellite stable colorectal liver metastases\u2014understanding the mechanisms of immune resistance","volume":"4","author":"Gholami","year":"2021","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jconrel.2026.114915_bb0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189198","article-title":"The key role of matrix stiffness in colorectal cancer immunotherapy: mechanisms and therapeutic strategies","volume":"1879","author":"Chen","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0200","doi-asserted-by":"crossref","first-page":"10217","DOI":"10.1021\/jacs.3c14005","article-title":"Nanomedicine remodels tumor microenvironment for solid tumor immunotherapy","volume":"146","author":"Guo","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114915_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.343","article-title":"Hot and cold tumors: immunological features and the therapeutic strategies","volume":"4","author":"Wang","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.jconrel.2026.114915_bb0210","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12943-025-02477-6","article-title":"Turning cold tumors into hot tumors to ignite immunotherapy","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0215","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114915_bb0220","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/cac2.12539","article-title":"Immunologic tumor microenvironment modulators for turning cold tumors hot","volume":"44","author":"Khosravi","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jconrel.2026.114915_bb0225","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217076","article-title":"Metabolic reprogramming in tumor immune microenvironment: impact on immune cell function and therapeutic implications","volume":"597","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb0230","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.86032","article-title":"Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis","volume":"12","author":"Wu","year":"2023","journal-title":"Elife"},{"key":"10.1016\/j.jconrel.2026.114915_bb0235","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/s41392-023-01452-1","article-title":"Macrophages in immunoregulation and therapeutics","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114915_bb0240","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.immuni.2014.06.008","article-title":"Macrophage activation and polarization: nomenclature and experimental guidelines","volume":"41","author":"Murray","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114915_bb0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109955","article-title":"Global characterization of macrophage polarization mechanisms and identification of m2-type polarization inhibitors","volume":"37","author":"He","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.114915_bb0250","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1158\/2326-6066.CIR-20-0527","article-title":"The prognostic role of macrophage polarization in the colorectal cancer microenvironment","volume":"9","author":"V\u00e4yrynen","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb0255","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40364-024-00573-1","article-title":"RUNX1 promotes angiogenesis in colorectal cancer by regulating the crosstalk between tumor cells and tumor associated macrophages","volume":"12","author":"Guo","year":"2024","journal-title":"Biomark. Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb0260","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114915_bb0265","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0270","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1038\/s41418-019-0312-y","article-title":"Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer","volume":"26","author":"Li","year":"2019","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2026.114915_bb0275","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s12964-020-00557-2","article-title":"Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression","volume":"18","author":"Liu","year":"2020","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.jconrel.2026.114915_bb0280","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/s41419-021-04166-w","article-title":"TCF4 enhances hepatic metastasis of colorectal cancer by regulating tumor-associated macrophage via CCL2\/CCR2 signaling","volume":"12","author":"Tu","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.114915_bb0285","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12943-022-01657-y","article-title":"Myeloid-derived suppressor cells: an emerging target for anticancer immunotherapy","volume":"21","author":"Wu","year":"2022","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0290","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40364-023-00475-8","article-title":"Myeloid-derived suppressor cells: key immunosuppressive regulators and therapeutic targets in hematological malignancies","volume":"11","author":"Wang","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb0295","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s12885-023-10526-w","article-title":"Notch3 signaling promotes colorectal tumor growth by enhancing immunosuppressive cells infiltration in the microenvironment","volume":"23","author":"Huang","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0300","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/s12951-024-02584-4","article-title":"Targeting CSF1R in myeloid-derived suppressor cells: insights into its immunomodulatory functions in colorectal cancer and therapeutic implications","volume":"22","author":"Tong","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0305","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12943-024-02208-3","article-title":"Myeloid-derived suppressor cells (MDSCs) in the tumor microenvironment and their targeting in cancer therapy","volume":"24","author":"He","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0310","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.cytogfr.2025.01.003","article-title":"Insights into IL-6\/JAK\/STAT3 signaling in the tumor microenvironment: implications for cancer therapy","volume":"85","author":"Thuya","year":"2025","journal-title":"Cytokine Growth Factor Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.modpat.2024.100450","article-title":"Quantitative multiplexed analysis of indoleamine 2, 3-dioxygenase (IDO) and arginase-1 (ARG1) expression and myeloid cell infiltration in colorectal cancer","volume":"37","author":"Elomaa","year":"2024","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0320","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40164-022-00296-9","article-title":"Myeloid-derived suppressor cells in hematologic malignancies: two sides of the same coin","volume":"11","author":"Yu","year":"2022","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0325","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/s41571-023-00846-y","article-title":"Myeloid-derived suppressor cells in cancer and cancer therapy","volume":"21","author":"Lasser","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0330","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114915_bb0335","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12943-024-02166-w","article-title":"Cellular mechanisms of combining innate immunity activation with PD-1\/PD-L1 blockade in treatment of colorectal cancer","volume":"23","author":"Xie","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0340","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s40164-024-00505-7","article-title":"Myeloid-derived suppressor cells in cancer: therapeutic targets to overcome tumor immune evasion","volume":"13","author":"Lu","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0345","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1007\/s00262-021-03081-5","article-title":"TGF-\u03b2 orchestrates the phenotype and function of monocytic myeloid-derived suppressor cells in colorectal cancer","volume":"71","author":"Gneo","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2026.114915_bb0350","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/s12943-024-02156-y","article-title":"Regulatory T cells in immune checkpoint blockade antitumor therapy","volume":"23","author":"Zhang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0355","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41571-024-00870-6","article-title":"Regulatory t cell-mediated immunosuppression orchestrated by cancer: towards an immuno-genomic paradigm for precision medicine","volume":"21","author":"Kumagai","year":"2024","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0360","doi-asserted-by":"crossref","first-page":"eadq9913","DOI":"10.1126\/scitranslmed.adq9913","article-title":"Conversion of pathogenic T cells into functionally stabilized Treg cells for antigen-specific immunosuppression in pemphigus vulgaris","volume":"17","author":"Mukai","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114915_bb0365","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41577-024-00994-x","article-title":"The regulation and differentiation of regulatory T cells and their dysfunction in autoimmune diseases","volume":"24","author":"Sumida","year":"2024","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0370","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.immuni.2021.04.005","article-title":"Distinct Foxp3 enhancer elements coordinate development, maintenance, and function of regulatory T cells","volume":"54","author":"Kawakami","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114915_bb0375","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106197","article-title":"Targeting T regulatory cells: their role in colorectal carcinoma progression and current clinical trials","volume":"178","author":"Bandaru","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb0380","doi-asserted-by":"crossref","first-page":"1602172","DOI":"10.3389\/fimmu.2025.1602172","article-title":"Transcriptional fingerprinting of regulatory T cells: ensuring quality in cell therapy applications","volume":"16","author":"Cheng","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0385","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.3389\/fimmu.2019.02936","article-title":"Immune checkpoints in circulating and tumor-infiltrating CD4+ T cell subsets in colorectal cancer patients","volume":"10","author":"Toor","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0390","article-title":"Treg: a promising immunotherapeutic target in oral diseases","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0395","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41577-020-0376-4","article-title":"Targeting CD39 in cancer","volume":"20","author":"Moesta","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0400","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12964-024-01711-w","article-title":"Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance","volume":"22","author":"Yang","year":"2024","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.jconrel.2026.114915_bb0405","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41423-021-00741-5","article-title":"Dendritic cells in cancer immunology","volume":"19","author":"Murphy","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0410","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","article-title":"Dendritic cells revisited","volume":"39","author":"Cabeza-Cabrerizo","year":"2021","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/s41568-024-00787-3","article-title":"Dendritic cell maturation in cancer","volume":"25","author":"Moon","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0420","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Del Prete","year":"2023","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0425","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1016\/j.immuni.2023.08.014","article-title":"Dendritic cells as shepherds of T cell immunity in cancer","volume":"56","author":"Pittet","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114915_bb0430","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","article-title":"Dendritic cells in cancer immunology and immunotherapy","volume":"20","author":"Wculek","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0435","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.immuni.2017.12.004","article-title":"Paracrine Wnt5a-\u03b2-catenin signaling triggers a metabolic program that drives dendritic cell tolerization","volume":"48","author":"Zhao","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2026.114915_bb0440","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"WNT\/\u03b2-catenin pathway activation correlates with immune exclusion across human cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb0445","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.724883","article-title":"The therapeutic potential of tackling tumor-induced dendritic cell dysfunction in colorectal cancer","volume":"12","author":"Subtil","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0450","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1105244","article-title":"Dendritic cell phenotype and function in a 3D co-culture model of patient-derived metastatic colorectal cancer organoids","volume":"14","author":"Subtil","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0455","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/s41419-025-08180-0","article-title":"The emerging role of dendritic cells in the tumor microenvironment: from antigen presentation to targeted immunotherapy","volume":"16","author":"Xie","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.114915_bb0460","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41577-022-00732-1","article-title":"Roles of natural killer cells in immunity to cancer, and applications to immunotherapy","volume":"23","author":"Wolf","year":"2023","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0465","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1158\/2159-8290.CD-20-0655","article-title":"Tumor-infiltrating natural killer cells","volume":"11","author":"C\u00f3zar","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2026.114915_bb0470","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12943-020-01238-x","article-title":"Natural killer cells in cancer biology and therapy","volume":"19","author":"Wu","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0475","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.ymthe.2019.03.011","article-title":"Adoptive transfer of NKG2D CAR mRNA-engineered natural killer cells in colorectal cancer patients","volume":"27","author":"Xiao","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2026.114915_bb0480","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.3390\/cells10061420","article-title":"NKG2D natural killer cell receptor\u2014a short description and potential clinical applications","volume":"10","author":"Siemaszko","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.114915_bb0485","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1126\/science.1258867","article-title":"A shed NKG2D ligand that promotes natural killer cell activation and tumor rejection","volume":"348","author":"Deng","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2026.114915_bb0490","doi-asserted-by":"crossref","first-page":"11067","DOI":"10.1021\/acsnano.9b10103","article-title":"Boosting natural killer cell-based cancer immunotherapy with selenocystine\/transforming growth factor-beta inhibitor-encapsulated nanoemulsion","volume":"14","author":"Liu","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb0495","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/s41467-024-44789-z","article-title":"Rapid functional impairment of natural killer cells following tumor entry limits anti-tumor immunity","volume":"15","author":"Dean","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114915_bb0500","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1038\/d41586-024-01427-4","article-title":"Natural killer cells show their cancer-fighting worth","volume":"629","author":"Keener","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114915_bb0505","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.216043","article-title":"CD8+ T cell exhaustion and cancer immunotherapy","volume":"559","author":"Wang","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb0510","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/s41590-024-01896-9","article-title":"T cell dysfunction and therapeutic intervention in cancer","volume":"25","author":"Zebley","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0515","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.intimp.2016.12.024","article-title":"Co-expression of TIM-3 and CEACAM1 promotes T cell exhaustion in colorectal cancer patients","volume":"43","author":"Zhang","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0520","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/s41571-022-00689-z","article-title":"Clinical implications of T cell exhaustion for cancer immunotherapy","volume":"19","author":"Chow","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0525","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1146\/annurev-immunol-090222-110914","article-title":"T cell exhaustion","volume":"42","author":"Baessler","year":"2024","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0530","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110331","article-title":"PD-1 blockade therapy promotes infiltration of tumor-attacking exhausted T cell clonotypes","volume":"38","author":"Nagasaki","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.jconrel.2026.114915_bb0535","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","article-title":"T-cell exhaustion in the tumor microenvironment","volume":"6","author":"Jiang","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.114915_bb0540","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1038\/s41388-023-02869-2","article-title":"Alleviating hypoxia to improve cancer immunotherapy","volume":"42","author":"Fan","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2026.114915_bb0545","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2015.06.005","article-title":"Hypoxia inducible factor-1\u03b1: its role in colorectal carcinogenesis and metastasis","volume":"366","author":"Nagaraju","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb0550","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12943-023-01744-8","article-title":"Extracellular matrix remodeling in tumor progression and immune escape: from mechanisms to treatments","volume":"22","author":"Yuan","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0555","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/j.apsb.2020.09.014","article-title":"Manipulation of immune\u2013vascular crosstalk: new strategies towards cancer treatment","volume":"10","author":"Zhao","year":"2020","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114915_bb0560","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/s41419-017-0061-0","article-title":"Defining the role of the tumor vasculature in antitumor immunity and immunotherapy","volume":"9","author":"Schaaf","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.114915_bb0565","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114915_bb0570","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.addr.2015.11.001","article-title":"Extracellular matrix structure","volume":"97","author":"Theocharis","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb0575","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/s41420-024-02015-1","article-title":"Current understanding of the interplay between extracellular matrix remodelling and gut permeability in health and disease","volume":"10","author":"Vilardi","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.114915_bb0580","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1158\/2159-8290.CD-24-0002","article-title":"The interplay between extracellular matrix remodeling and cancer therapeutics","volume":"14","author":"Prakash","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2026.114915_bb0585","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s41419-024-06697-4","article-title":"Modulating extracellular matrix stiffness: a strategic approach to boost cancer immunotherapy","volume":"15","author":"Mai","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.jconrel.2026.114915_bb0590","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1186\/s13046-022-02484-1","article-title":"The extracellular matrix alteration, implication in modulation of drug resistance mechanism: friends or foes?","volume":"41","author":"Jurj","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb0595","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.7150\/thno.72853","article-title":"The landscape of cancer-associated fibroblasts in colorectal cancer liver metastases","volume":"12","author":"Giguelay","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114915_bb0600","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/s41568-024-00740-4","article-title":"CAF-induced physical constraints controlling T cell state and localization in solid tumours","volume":"24","author":"Arpinati","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0605","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114915_bb0610","doi-asserted-by":"crossref","first-page":"1425687","DOI":"10.3389\/fimmu.2024.1425687","article-title":"Hypoxia reconstructed colorectal tumor microenvironment weakening anti-tumor immunity: construction of a new prognosis predicting model through transcriptome analysis","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0615","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/nri.2017.103","article-title":"Regulation of immunity and inflammation by hypoxia in immunological niches","volume":"17","author":"Taylor","year":"2017","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0620","article-title":"Modulating cancer mechanopathology to restore vascular function and enhance immunotherapy","volume":"5","author":"Mpekris","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.jconrel.2026.114915_bb0625","doi-asserted-by":"crossref","first-page":"2402720","DOI":"10.1002\/adma.202402720","article-title":"Expanded ROS generation and hypoxia reversal: excipient-free self-assembled nanotheranostics for enhanced cancer photodynamic immunotherapy","volume":"36","author":"Yang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb0630","doi-asserted-by":"crossref","first-page":"2305728","DOI":"10.1002\/smll.202305728","article-title":"TAM-hijacked immunoreaction rescued by hypoxia-pathway-intervened strategy for enhanced metastatic cancer immunotherapy","volume":"20","author":"Jiang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114915_bb0635","doi-asserted-by":"crossref","first-page":"1549276","DOI":"10.3389\/fimmu.2025.1549276","article-title":"Research progress of HIF-1a on immunotherapy outcomes in immune vascular microenvironment","volume":"16","author":"Shi","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0640","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumour-associated macrophages by tumour-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114915_bb0645","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2024.189137","article-title":"The cellular-centered view of hypoxia tumor microenvironment: molecular mechanisms and therapeutic interventions","volume":"1879","author":"Zhang","year":"2024","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0650","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13045-022-01292-6","article-title":"Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape","volume":"15","author":"Wu","year":"2022","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0655","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/nm.3541","article-title":"Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors","volume":"20","author":"Motz","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2026.114915_bb0660","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/s41568-024-00736-0","article-title":"Targeting the tumour vasculature: from vessel destruction to promotion","volume":"24","author":"Guelfi","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0665","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.coi.2015.01.011","article-title":"Targeting the tumor vasculature to enhance t cell activity","volume":"33","author":"Lanitis","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0670","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20140559","article-title":"VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors","volume":"212","author":"Voron","year":"2015","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2026.114915_bb0675","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/JLB.5RU0222-082R","article-title":"Direct and indirect regulation of the tumor immune microenvironment by VEGF","volume":"111","author":"Zhang","year":"2022","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0680","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10456-017-9562-9","article-title":"Tumor angiogenesis and vascular normalization: alternative therapeutic targets","volume":"20","author":"Viallard","year":"2017","journal-title":"Angiogenesis"},{"key":"10.1016\/j.jconrel.2026.114915_bb0685","doi-asserted-by":"crossref","first-page":"2205563","DOI":"10.1002\/advs.202205563","article-title":"Role of the gut microbiota and its metabolites in tumorigenesis or development of colorectal cancer","volume":"10","author":"Qu","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb0690","doi-asserted-by":"crossref","first-page":"2236364","DOI":"10.1080\/19490976.2023.2236364","article-title":"Colorectal cancer and gut microbiota studies in China","volume":"15","author":"Wang","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.jconrel.2026.114915_bb0695","first-page":"1","article-title":"The microbiome and cancer: understanding the role of microorganisms in tumor development and treatment","author":"Naik","year":"2024","journal-title":"Microbiome Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0700","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1038\/s41467-024-47523-x","article-title":"Consistent signatures in the human gut microbiome of old-and young-onset colorectal cancer","volume":"15","author":"Qin","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114915_bb0705","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.chom.2025.05.004","article-title":"Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity","volume":"33","author":"Ding","year":"2025","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.jconrel.2026.114915_bb0710","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanmic.2024.101015","article-title":"Geographical variation in the incidence of colorectal cancer and urinary tract cancer is associated with population exposure to colibactin-producing Escherichia coli","volume":"6","author":"M\u00e4klin","year":"2025","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.jconrel.2026.114915_bb0715","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s42255-025-01287-w","article-title":"The gut microbiome and cancer: from tumorigenesis to therapy","volume":"7","author":"Nobels","year":"2025","journal-title":"Nat. Metab."},{"key":"10.1016\/j.jconrel.2026.114915_bb0720","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12943-025-02227-8","article-title":"The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications","volume":"24","author":"Ding","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0725","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/iej.12185","article-title":"Fusobacterium nucleatum induces cytokine production through Toll-like-receptor-independent mechanism","volume":"47","author":"Quah","year":"2014","journal-title":"Int. Endod. J."},{"key":"10.1016\/j.jconrel.2026.114915_bb0730","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41579-025-01237-z","article-title":"Fusobacterium nucleatum: ecology, pathogenesis and clinical implications","volume":"24","author":"Jiang","year":"2025","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0735","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3390\/cancers17030368","article-title":"Unraveling the role of Fusobacterium nucleatum in colorectal cancer: molecular mechanisms and pathogenic insights","volume":"17","author":"Galasso","year":"2025","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2026.114915_bb0740","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/s41392-024-01868-3","article-title":"Targeting cytokine and chemokine signaling pathways for cancer therapy","volume":"9","author":"Yi","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114915_bb0745","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.3390\/cells11152313","article-title":"The role of inflammatory mediators in colorectal cancer hepatic metastasis","volume":"11","author":"Goodla","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.jconrel.2026.114915_bb0750","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/gutjnl-2021-325808","article-title":"Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases","volume":"72","author":"Sullivan","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jconrel.2026.114915_bb0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188758","article-title":"Targeting interleukin-17 enhances tumor response to immune checkpoint inhibitors in colorectal cancer","volume":"1877","author":"Li","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0760","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1158\/1535-7163.MCT-23-0242","article-title":"IL-35: new target for immunotherapy targeting the tumor microenvironment","volume":"23","author":"Yi","year":"2024","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.jconrel.2026.114915_bb0765","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.7150\/ijbs.46651","article-title":"The role of interleukins in colorectal cancer","volume":"16","author":"Li","year":"2020","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb0770","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41423-021-00735-3","article-title":"IFN\u03b3 signaling integrity in colorectal cancer immunity and immunotherapy","volume":"19","author":"Du","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0775","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/nri3896","article-title":"Emerging cytokine networks in colorectal cancer","volume":"15","author":"West","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0780","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.semcancer.2023.04.007","article-title":"Roles of TGF-\u03b2 signals in tumor microenvironment via regulation of the formation and plasticity of vascular system","volume":"92","author":"Watabe","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0785","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41392-024-01764-w","article-title":"TGF-\u03b2 signaling in health, disease and therapeutics","volume":"9","author":"Deng","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.jconrel.2026.114915_bb0790","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13046-025-03302-0","article-title":"Tumor secretome shapes the immune landscape during cancer progression","volume":"44","author":"Yang","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb0795","doi-asserted-by":"crossref","first-page":"52294","DOI":"10.18632\/oncotarget.10561","article-title":"TGF-\u03b2 induces m2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.jconrel.2026.114915_bb0800","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrd.2015.17","article-title":"Ten years of anti-vascular endothelial growth factor therapy","volume":"15","author":"Ferrara","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114915_bb0805","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s13046-020-01709-5","article-title":"The role of microenvironment in tumor angiogenesis","volume":"39","author":"Jiang","year":"2020","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb0810","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s12032-019-1329-2","article-title":"The role of vascular endothelial growth factor in the hypoxic and immunosuppressive tumor microenvironment: perspectives for therapeutic implications","volume":"37","author":"Tamura","year":"2020","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0815","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12929-025-01119-9","article-title":"EGF receptor in organ development, tissue homeostasis and regeneration","volume":"32","author":"Tito","year":"2025","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb0820","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb0825","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/ijms26020625","article-title":"Identification of immune infiltration-associated CC motif chemokine ligands as biomarkers and targets for colorectal cancer prevention and immunotherapy","volume":"26","author":"Liu","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb0830","doi-asserted-by":"crossref","first-page":"166","DOI":"10.31083\/j.fbl2904166","article-title":"The chemokine CXCL7 is correlated with LDH-A and predicts the prognosis of patients with colorectal cancer","volume":"29","author":"Liang","year":"2024","journal-title":"Front. Biosci. Landmark"},{"key":"10.1016\/j.jconrel.2026.114915_bb0835","doi-asserted-by":"crossref","first-page":"4725","DOI":"10.1158\/0008-5472.CAN-06-3424","article-title":"High-level expression of chemokine CXCL16 by tumor cells correlates with a good prognosis and increased tumor-infiltrating lymphocytes in colorectal cancer","volume":"67","author":"Hojo","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb0840","doi-asserted-by":"crossref","first-page":"4691","DOI":"10.2147\/CMAR.S197354","article-title":"Elevated expression of CXCL16 correlates with poor prognosis in patients with colorectal cancer","author":"Chen","year":"2019","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb0845","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2023.101854","article-title":"CXCL16 promotes tumor metastasis by regulating angiogenesis in the tumor micro-environment of BRAF V600E mutant colorectal cancer","volume":"41","author":"Deng","year":"2024","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0850","doi-asserted-by":"crossref","first-page":"1404768","DOI":"10.3389\/fimmu.2024.1404768","article-title":"Chemokine family significance and prognostic value in colorectal cancer","volume":"15","author":"Ding","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0855","doi-asserted-by":"crossref","first-page":"1400722","DOI":"10.3389\/fimmu.2024.1400722","article-title":"Establishment of a chemokine-based prognostic model and identification of CXCL10+ M1 macrophages as predictors of neoadjuvant therapy efficacy in colorectal cancer","volume":"15","author":"Tuersun","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0860","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/cac2.12295","article-title":"Cytokine-and chemokine-induced inflammatory colorectal tumor microenvironment: emerging avenue for targeted therapy","volume":"42","author":"Bhat","year":"2022","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jconrel.2026.114915_bb0865","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.canlet.2015.02.021","article-title":"CXCL8, overexpressed in colorectal cancer, enhances the resistance of colorectal cancer cells to anoikis","volume":"361","author":"Xiao","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb0870","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202201982RRR","article-title":"CXCL8 induces M2 macrophage polarization and inhibits CD8+ t cell infiltration to generate an immunosuppressive microenvironment in colorectal cancer","volume":"37","author":"Shao","year":"2023","journal-title":"FASEB J."},{"key":"10.1016\/j.jconrel.2026.114915_bb0875","doi-asserted-by":"crossref","first-page":"2312169","DOI":"10.1002\/adma.202312169","article-title":"Nanomedicine tumor targeting","volume":"36","author":"Lammers","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb0880","doi-asserted-by":"crossref","first-page":"5626","DOI":"10.1039\/D5BM01176K","article-title":"Next-generation nanocarriers for colorectal cancer: passive, active, and stimuli-responsive strategies for precision therapy","volume":"13","author":"Mohamed","year":"2025","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb0885","doi-asserted-by":"crossref","first-page":"8073","DOI":"10.7150\/thno.37198","article-title":"Alliance with EPR effect: combined strategies to improve the EPR effect in the tumor microenvironment","volume":"9","author":"Park","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114915_bb0890","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2022.114447","article-title":"The role of imaging in targeted delivery of nanomedicine for cancer therapy","volume":"189","author":"Li","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb0895","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2147\/IJN.S232777","article-title":"Tumor targeted curcumin delivery by folate-modified MPEG-PCL self-assembly micelles for colorectal cancer therapy","volume":"15","author":"Hu","year":"2020","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114915_bb0900","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.161104","article-title":"Nano-immunomodulators for multi-pathway regulation of immunosuppressive microenvironment of colorectal cancer","volume":"508","author":"Cao","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.114915_bb0905","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3390\/jpm13030389","article-title":"Approaches to improve EPR-based drug delivery for cancer therapy and diagnosis","volume":"13","author":"Subhan","year":"2023","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.jconrel.2026.114915_bb0910","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jconrel.2024.01.072","article-title":"Locoregional drug delivery for cancer therapy: preclinical progress and clinical translation","volume":"367","author":"Shaha","year":"2024","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114915_bb0915","doi-asserted-by":"crossref","first-page":"9761","DOI":"10.1021\/acs.nanolett.1c03708","article-title":"A duplex CRISPR-Cas9 ribonucleoprotein nanomedicine for colorectal cancer gene therapy","volume":"21","author":"Wan","year":"2021","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb0920","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.125163","article-title":"Dual-targeting of artesunate and chloroquine to tumor cells and tumor-associated macrophages by a biomimetic PLGA nanoparticle for colorectal cancer treatment","volume":"244","author":"Peng","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0925","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s12929-024-01069-8","article-title":"EpCAM-targeted betulinic acid analogue nanotherapy improves therapeutic efficacy and induces anti-tumorigenic immune response in colorectal cancer tumor microenvironment","volume":"31","author":"Dutta","year":"2024","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb0930","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.actbio.2022.08.020","article-title":"Bidirectional anisotropic palladium nanozymes reprogram macrophages to enhance collaborative chemodynamic therapy of colorectal cancer","volume":"151","author":"Chen","year":"2022","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114915_bb0935","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.133516","article-title":"Incorporating mannose-functionalized hydroxyapatite\/metal-organic framework into the hyaluronic acid hydrogel film: a potential dual-targeted oral anticancer delivery system","volume":"274","author":"Poursadegh","year":"2024","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0940","doi-asserted-by":"crossref","first-page":"1700111","DOI":"10.1002\/adhm.201700111","article-title":"Panitumumab-conjugated Pt-drug nanomedicine for enhanced efficacy of combination targeted chemotherapy against colorectal cancer","volume":"6","author":"Tsai","year":"2017","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb0945","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.actbio.2022.11.043","article-title":"Functionalized biomimetic nanoparticles combining programmed death-1\/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy","volume":"157","author":"Xiao","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114915_bb0950","first-page":"2833","article-title":"In vivo tumor targeting and imaging with anti-vascular endothelial growth factor antibody-conjugated dextran-coated iron oxide nanoparticles","volume":"7","author":"Hsieh","year":"2012","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114915_bb0955","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jconrel.2017.05.004","article-title":"Therapeutic targeting strategies using endogenous cells and proteins","volume":"258","author":"Parayath","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114915_bb0960","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41578-022-00529-7","article-title":"Passive, active and endogenous organ-targeted lipid and polymer nanoparticles for delivery of genetic drugs","volume":"8","author":"Dilliard","year":"2023","journal-title":"Nat. Rev. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb0965","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.138342","article-title":"5-Fluorouracil-loaded chitosan nanoparticles conjugated with methotrexate for targeted therapy of colorectal cancer","volume":"287","author":"Dos Santos","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0970","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123585","article-title":"Folic acid-decorated alginate nanoparticles loaded hydrogel for the oral delivery of diferourylmethane in colorectal cancer","volume":"233","author":"Abbasi","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.jconrel.2026.114915_bb0975","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.2147\/IJN.S132929","article-title":"SL2B aptamer and folic acid dual-targeting DNA nanostructures for synergic biological effect with chemotherapy to combat colorectal cancer","volume":"12","author":"Sun","year":"2017","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114915_bb0980","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.3109\/10717544.2015.1084400","article-title":"Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors","volume":"23","author":"Tummala","year":"2016","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jconrel.2026.114915_bb0985","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.jconrel.2018.04.052","article-title":"Magnetically driven drug delivery systems improving targeted immunotherapy for colon-rectal cancer","volume":"280","author":"Grifantini","year":"2018","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114915_bb0990","doi-asserted-by":"crossref","first-page":"7185","DOI":"10.1039\/D3NR04118B","article-title":"Photoactive imaging and therapy for colorectal cancer using a CEA-Affimer conjugated Foslip nanoparticle","volume":"16","author":"Khaled","year":"2024","journal-title":"Nanoscale"},{"key":"10.1016\/j.jconrel.2026.114915_bb0995","doi-asserted-by":"crossref","first-page":"6096","DOI":"10.1021\/acsami.7b13431","article-title":"Panitumumab-conjugated and platinum-cored pH-sensitive apoferritin nanocages for colorectal cancer-targeted therapy","volume":"10","author":"Lin","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2026.114915_bb1000","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.actbio.2019.09.002","article-title":"Collaborative membrane activity and receptor-dependent tumor cell targeting for precise nanoparticle delivery in CXCR4+ colorectal cancer","volume":"99","author":"Sala","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1005","doi-asserted-by":"crossref","first-page":"6436","DOI":"10.1021\/acsanm.9b01392","article-title":"Gold nanoparticle aggregates functionalized with cyclic RGD peptides for targeting and imaging of colorectal cancer cells","volume":"2","author":"Biscaglia","year":"2019","journal-title":"ACS Appl. Nano Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1010","doi-asserted-by":"crossref","DOI":"10.1016\/j.msec.2019.110594","article-title":"Silencing KLK12 expression via RGDfC-decorated selenium nanoparticles for the treatment of colorectal cancer in vitro and in vivo","volume":"110","author":"Xia","year":"2020","journal-title":"Mater. Sci. Eng. C-Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1015","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2147\/IJN.S492734","article-title":"LBP-CD155 liposome nanovaccine efficiently resist colorectal cancer and enhance ICB therapy","volume":"20","author":"Yan","year":"2025","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114915_bb1020","doi-asserted-by":"crossref","first-page":"1700403","DOI":"10.1002\/adfm.201700403","article-title":"Dual-targeting to cancer cells and M2 macrophages via biomimetic delivery of mannosylated albumin nanoparticles for drug-resistant cancer therapy","volume":"27","author":"Zhao","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1025","doi-asserted-by":"crossref","first-page":"12579","DOI":"10.1021\/jacs.0c05039","article-title":"Nanoscale metal\u2013organic framework co-delivers TLR-7 agonists and anti-CD47 antibodies to modulate macrophages and orchestrate cancer immunotherapy","volume":"142","author":"Ni","year":"2020","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114915_bb1030","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jare.2018.06.005","article-title":"Smart nanocarrier-based drug delivery systems for cancer therapy and toxicity studies: a review","volume":"15","author":"Hossen","year":"2019","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1035","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.121091","article-title":"Co-assembled nanocomplexes of peptide neoantigen adpgk and toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy","volume":"608","author":"Liang","year":"2021","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114915_bb1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106184","article-title":"Advances in intelligent-responsive nanocarriers for cancer therapy","volume":"178","author":"Tian","year":"2022","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1045","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1021\/acsnano.6b01296","article-title":"Rational design of multi-stimuli-responsive nanoparticles for precise cancer therapy","volume":"10","author":"An","year":"2016","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1050","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2022.102728","article-title":"Release of bioactive compounds from delivery systems by stimuli-responsive approaches; triggering factors, mechanisms, and applications","volume":"307","author":"Rezaei","year":"2022","journal-title":"Adv. Colloid Interf. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb1055","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.actbio.2023.11.019","article-title":"Amphiphilic polymeric nanodrug integrated with superparamagnetic iron oxide nanoparticles for synergistic antibacterial and antitumor therapy of colorectal cancer","volume":"173","author":"Li","year":"2024","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114006","article-title":"Engineering of stimuli-responsive self-assembled biomimetic nanoparticles","volume":"179","author":"Krishnan","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb1065","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.jconrel.2023.04.040","article-title":"Unleashing the potential of cell biomimetic nanoparticles: strategies and challenges in their design and fabrication for therapeutic applications","volume":"358","author":"Zinger","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114915_bb1070","article-title":"Nanomedicine reimagined: translational strategies for precision tumor theranostics","volume":"38","author":"Wu","year":"2025","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1075","doi-asserted-by":"crossref","first-page":"13983","DOI":"10.1021\/acsnano.4c00182","article-title":"Mechanisms and barriers in nanomedicine: progress in the field and future directions","volume":"18","author":"Anchordoquy","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1080","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2023.103045","article-title":"Progress and challenges in the translation of cancer nanomedicines","volume":"85","author":"Tong","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1085","first-page":"1973","article-title":"The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment","volume":"6","author":"Yang","year":"2021","journal-title":"Bioact. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1090","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13046-022-02272-x","article-title":"Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies","volume":"41","author":"Kumari","year":"2022","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1095","doi-asserted-by":"crossref","first-page":"2201275","DOI":"10.1002\/adfm.202201275","article-title":"Boosting tumor immunotherapy by bioactive nanoparticles via ca2+ interference mediated TME reprogramming and specific PD-L1 depletion","volume":"32","author":"An","year":"2022","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1100","doi-asserted-by":"crossref","first-page":"2411247","DOI":"10.1002\/adfm.202411247","article-title":"Boosting Ferroptosis and immunotherapy for colorectal cancer by lactate-related metabolic reprogramming","volume":"34","author":"Li","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1105","doi-asserted-by":"crossref","first-page":"3589","DOI":"10.2147\/IJN.S450205","article-title":"Regulating tumor-associated macrophage polarization by cyclodextrin-modified PLGA nanoparticles loaded with r848 for treating colon cancer","volume":"19","author":"Yuan","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114915_bb1110","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.114915_bb1115","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.1007\/s13346-025-01896-8","article-title":"Immunostimulatory effects of IL-12 targeted pH-responsive nanoparticles in macrophage-enriched 3D immuno-spheroids in vitro model","volume":"15","author":"Silveira","year":"2025","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1120","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1021\/acsnano.3c10037","article-title":"Tumor-microenvironment-activatable nanoparticle mediating immunogene therapy and M2 macrophage-targeted inhibitor for synergistic cancer immunotherapy","volume":"18","author":"Hu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jddst.2023.105237","article-title":"Macrophage membrane-coated self-assembled curcumin nanoparticle missile for the treatment of colorectal cancer","volume":"91","author":"Liu","year":"2024","journal-title":"J. Drug Delivery Sci. Technol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1130","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jcis.2023.10.054","article-title":"M1 macrophage-derived exosome for reprograming M2 macrophages and combining endogenous NO gas therapy with enhanced photodynamic synergistic therapy in colorectal cancer","volume":"654","author":"Zhang","year":"2024","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb1135","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.658","article-title":"Macrophage plasticity: signaling pathways, tissue repair, and regeneration","volume":"5","author":"Yan","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.jconrel.2026.114915_bb1140","doi-asserted-by":"crossref","first-page":"10009","DOI":"10.3390\/ijms221810009","article-title":"Nanoparticles targeting innate immune cells in tumor microenvironment","volume":"22","author":"Jang","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb1145","doi-asserted-by":"crossref","first-page":"10161","DOI":"10.1158\/0008-5472.CAN-10-1921","article-title":"The inflammasome component NLRP3 impairs antitumor vaccine by enhancing the accumulation of tumor-associated myeloid-derived suppressor cells","volume":"70","author":"Van Deventer","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.889075","article-title":"Ablation of NLRP3 inflammasome rewires MDSC function and promotes tumor regression","volume":"13","author":"Papafragkos","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1155","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2024.122533","article-title":"MDSC-targeting gold nanoparticles enhance PD-1 tumor immunotherapy by inhibiting NLRP3 inflammasomes","volume":"307","author":"Zhu","year":"2024","journal-title":"Biomater"},{"key":"10.1016\/j.jconrel.2026.114915_bb1160","doi-asserted-by":"crossref","first-page":"2402456","DOI":"10.1002\/adma.202402456","article-title":"Unzippable siamese nanoparticles for programmed two-stage cancer immunotherapy","volume":"36","author":"Long","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1165","doi-asserted-by":"crossref","first-page":"1574327","DOI":"10.3389\/fimmu.2025.1574327","article-title":"The role of treg cells in colorectal cancer and the immunotherapy targeting treg cells","volume":"16","author":"Yu","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1170","doi-asserted-by":"crossref","first-page":"2400485","DOI":"10.1002\/advs.202400485","article-title":"Regulation of CTLs\/tregs via highly stable and ultrasound-responsive cerasomal nano-modulators for enhanced colorectal cancer immunotherapy","volume":"11","author":"Zhang","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb1175","first-page":"769","article-title":"The current role of dendritic cells in the progression and treatment of colorectal cancer, cancer","volume":"21","author":"Zhang","year":"2024","journal-title":"Biol. Med."},{"key":"10.1016\/j.jconrel.2026.114915_bb1180","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/cac2.12596","article-title":"Dysfunction of dendritic cells in tumor microenvironment and immunotherapy","volume":"44","author":"Chen","year":"2024","journal-title":"Cancer Commun."},{"key":"10.1016\/j.jconrel.2026.114915_bb1185","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1021\/acsnano.7b00978","article-title":"Efficient nanovaccine delivery in cancer immunotherapy","volume":"11","author":"Zhu","year":"2017","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1190","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.120844","article-title":"Personalized combination nano-immunotherapy for robust induction and tumor infiltration of CD8+ T cells","volume":"274","author":"Park","year":"2021","journal-title":"Biomater"},{"key":"10.1016\/j.jconrel.2026.114915_bb1195","doi-asserted-by":"crossref","first-page":"eaaw6071","DOI":"10.1126\/sciadv.aaw6071","article-title":"A bi-adjuvant nanovaccine that potentiates immunogenicity of neoantigen for combination immunotherapy of colorectal cancer","volume":"6","author":"Ni","year":"2020","journal-title":"Sci. Adv."},{"key":"10.1016\/j.jconrel.2026.114915_bb1200","doi-asserted-by":"crossref","first-page":"9437","DOI":"10.2147\/IJN.S479334","article-title":"PLGA-Astragalus polysaccharide nanovaccines exert therapeutic effect in colorectal cancer","volume":"19","author":"Cao","year":"2024","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114915_bb1205","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2147\/IJN.S408521","article-title":"Cancer cell membrane-coated gambogic acid nanoparticles for effective anticancer vaccination by activating dendritic cells","volume":"18","author":"Huang","year":"2023","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114915_bb1210","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/s12943-020-01247-w","article-title":"CGAS-STING pathway in cancer biotherapy","volume":"19","author":"Wang","year":"2020","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb1215","first-page":"1452","article-title":"The cGAS\u2013STING pathway and cancer","volume":"3","author":"Samson","year":"2022","journal-title":"Nat. Can."},{"key":"10.1016\/j.jconrel.2026.114915_bb1220","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114020","article-title":"Delivery of STING agonists for adjuvanting subunit vaccines","volume":"179","author":"Van Herck","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb1225","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102273","article-title":"In-situ vaccination immunotherapy of colorectal cancer with STING agonist-integrated supramolecular nanovectors","volume":"56","author":"Liu","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.114915_bb1230","doi-asserted-by":"crossref","DOI":"10.1016\/j.eurpolymj.2024.113379","article-title":"cGAS-STING activation by nanodelivery of teniposide achieves colorectal cancer chemo-immunotherapy","volume":"219","author":"Liao","year":"2024","journal-title":"Eur. Polym. J."},{"key":"10.1016\/j.jconrel.2026.114915_bb1235","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1186\/s12951-024-02836-3","article-title":"A metal-organic nanoframework for efficient colorectal cancer immunotherapy by the cGAS-STING pathway activation and immune checkpoint blockade","volume":"22","author":"Zhang","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1240","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/j.ccell.2024.05.005","article-title":"RNA vaccines for cancer: principles to practice","volume":"42","author":"Guasp","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.jconrel.2026.114915_bb1245","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1384","article-title":"mRNA vaccine in cancer therapy: current advance and future outlook","volume":"13","author":"Li","year":"2023","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114915_bb1250","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1039\/D1MH01969D","article-title":"Tumor-targeted nano-delivery system of therapeutic RNA","volume":"9","author":"Wang","year":"2022","journal-title":"Mater. Horiz."},{"key":"10.1016\/j.jconrel.2026.114915_bb1255","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature18300","article-title":"Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy","volume":"534","author":"Kranz","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2026.114915_bb1260","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1571212","article-title":"Regulation of immunogenic cell death and potential applications in cancer therapy","volume":"16","author":"Fang","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1265","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21147\/j.issn.1000-9604.2022.01.01","article-title":"Inducing immunogenic cell death in immuno-oncological therapies","volume":"34","author":"Ti","year":"2022","journal-title":"Chin. J. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1270","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41568-024-00674-x","article-title":"Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity","volume":"24","author":"Meier","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb1275","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121425","article-title":"Engineered nanomaterials for synergistic photo-immunotherapy","volume":"282","author":"Guo","year":"2022","journal-title":"Biomater"},{"key":"10.1016\/j.jconrel.2026.114915_bb1280","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108180","article-title":"Biomaterial-assisted photoimmunotherapy for synergistic suppression of cancer progression","volume":"34","author":"Li","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb1285","doi-asserted-by":"crossref","first-page":"2204932","DOI":"10.1002\/advs.202204932","article-title":"Hybrid nanomaterials for cancer immunotherapy","volume":"10","author":"Li","year":"2023","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb1290","doi-asserted-by":"crossref","first-page":"2300524","DOI":"10.1002\/adhm.202300524","article-title":"Self-immolated nanoadjuvant for in situ vaccination immunotherapy of colorectal cancer","volume":"12","author":"Wang","year":"2023","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1295","doi-asserted-by":"crossref","first-page":"2423200","DOI":"10.1002\/adfm.202423200","article-title":"Fibroblast-activation protein targeted immunostimulant to provoke colorectal cancer immunity through photodynamic depleting and chemotherapeutic silencing of cancer associated fibroblasts","volume":"35","author":"Chen","year":"2025","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1300","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.actbio.2020.01.012","article-title":"Tumor-targeted nanoplatform for in situ oxygenation-boosted immunogenic phototherapy of colorectal cancer","volume":"104","author":"He","year":"2020","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1305","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2024.124968","article-title":"Tricomponent immunoactivating nanomedicine to downregulate PD-L1 and polarize macrophage for photodynamic immunotherapy of colorectal cancer","volume":"668","author":"Kong","year":"2025","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2026.114915_bb1310","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1021\/acsnano.4c16128","article-title":"Cell-penetrating peptide like anti-programmed cell death-ligand 1 peptide conjugate-based self-assembled nanoparticles for immunogenic photodynamic therapy","volume":"19","author":"Lee","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1315","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1021\/acs.biomac.5c01170","article-title":"Multifunctional nanoplatform combining photothermal therapy and chemoimmunotherapy for the treatment of Escherichia coli-colonized colorectal cancer","volume":"26","author":"Li","year":"2025","journal-title":"Biomacromolecules"},{"key":"10.1016\/j.jconrel.2026.114915_bb1320","doi-asserted-by":"crossref","DOI":"10.1016\/j.cclet.2023.108201","article-title":"Indocyanine green\u2212\/TLR7 agonist-constructed thermosensitive liposome for low-temperature PTT induced synergistic immunotherapy of colorectal cancer","volume":"34","author":"Sun","year":"2023","journal-title":"Chin. Chem. Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb1325","doi-asserted-by":"crossref","first-page":"26666","DOI":"10.1021\/acsnano.4c05773","article-title":"A multifunctional biomimetic nanoplatform for dual tumor targeting-assisted multimodal therapy of colon cancer","volume":"18","author":"Wan","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1330","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2024.102419","article-title":"Deciphering single-cell transcriptomic landscape of tumors in colorectal cancer treated with photothermal semiconducting polymers to design the combination therapy with checkpoint blockades for inhibition of tumor progression and metastasis","volume":"58","author":"Yuan","year":"2024","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.114915_bb1335","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1186\/s12951-024-02909-3","article-title":"Photothermal Fe3O4 nanoparticles induced immunogenic ferroptosis for synergistic colorectal cancer therapy","volume":"22","author":"Li","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1340","doi-asserted-by":"crossref","first-page":"3651","DOI":"10.1021\/acsnano.3c11436","article-title":"An oral nanomedicine elicits in situ vaccination effect against colorectal cancer","volume":"18","author":"Zu","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1345","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1016\/j.apsb.2025.03.046","article-title":"Metabolic reprogramming nanomedicine potentiates colon cancer sonodynamic immunotherapy by inhibiting the CD39\/CD73\/ADO pathway","volume":"15","author":"Zhang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.jconrel.2026.114915_bb1350","doi-asserted-by":"crossref","first-page":"2316092","DOI":"10.1002\/adfm.202316092","article-title":"Programmable bacteria-based biohybrids as living biotherapeutics for enhanced cancer sonodynamic-immunotherapy","volume":"34","author":"Wang","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1355","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.163582","article-title":"Innovative immunosonogen nanoplatform combining sonodynamic oxygenation and immunomodulation for superior cancer therapy","volume":"515","author":"Tang","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.114915_bb1360","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.actbio.2023.04.001","article-title":"Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-\u03b2 to boost immune response against colorectal cancer and liver metastasis","volume":"164","author":"Huang","year":"2023","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1365","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwac169","article-title":"Nanocatalytic bacteria disintegration reverses immunosuppression of colorectal cancer","volume":"9","author":"Jiang","year":"2022","journal-title":"Natl. Sci. Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb1370","doi-asserted-by":"crossref","first-page":"11998","DOI":"10.7150\/thno.50806","article-title":"In situ tuning proangiogenic factor-mediated immunotolerance synergizes the tumoricidal immunity via a hypoxia-triggerable liposomal bio-nanoreactor","volume":"10","author":"Chen","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114915_bb1375","doi-asserted-by":"crossref","first-page":"9152","DOI":"10.1039\/D0CS01370F","article-title":"Overcoming barriers in photodynamic therapy harnessing nano-formulation strategies","volume":"50","author":"Xie","year":"2021","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb1380","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.7150\/thno.73566","article-title":"Progress in advanced nanotherapeutics for enhanced photodynamic immunotherapy of tumor","volume":"12","author":"Wei","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114915_bb1385","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1186\/s12951-021-01080-3","article-title":"Recent advances in selective photothermal therapy of tumor","volume":"19","author":"Zhao","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1390","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2021.214330","article-title":"Low temperature photothermal therapy: advances and perspectives","volume":"454","author":"Yang","year":"2022","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb1395","doi-asserted-by":"crossref","first-page":"6427","DOI":"10.2147\/IJN.S388996","article-title":"Combined photodynamic and photothermal therapy and immunotherapy for cancer treatment: a review","volume":"17","author":"Kong","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114915_bb1400","doi-asserted-by":"crossref","first-page":"9816594","DOI":"10.34133\/2021\/9816594","article-title":"Low-temperature photothermal therapy: strategies and applications","volume":"2021","author":"Yi","year":"2021","journal-title":"Research"},{"key":"10.1016\/j.jconrel.2026.114915_bb1405","doi-asserted-by":"crossref","first-page":"7979","DOI":"10.1021\/acsnano.3c00891","article-title":"Photodynamic and photothermal therapies: synergy opportunities for nanomedicine","volume":"17","author":"Overchuk","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1410","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmmm.2023.170817","article-title":"Mesoporous Fe3O4 nanoparticle: a prospective nano heat generator for thermo-therapeutic cancer treatment modality","volume":"578","author":"Shaw","year":"2023","journal-title":"J. Magn. Magn. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1415","doi-asserted-by":"crossref","first-page":"2303059","DOI":"10.1002\/adma.202303059","article-title":"Organic sonodynamic materials for combination cancer immunotherapy","volume":"35","author":"Zhang","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1420","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s40820-025-01666-8","article-title":"Nanomaterials enhanced sonodynamic therapy for multiple tumor treatment","volume":"17","author":"Yang","year":"2025","journal-title":"Nano-Micro Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb1425","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1021\/accountsmr.2c00106","article-title":"Nanomaterials-based tumor microenvironment modulation for magnifying sonodynamic therapy","volume":"3","author":"Song","year":"2022","journal-title":"Acc. Mater. Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1430","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/acsnano.9b08550","article-title":"Combined magnetic hyperthermia and immune therapy for primary and metastatic tumor treatments","volume":"14","author":"Pan","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1435","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.7150\/thno.40805","article-title":"Comprehensive understanding of magnetic hyperthermia for improving antitumor therapeutic efficacy","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114915_bb1440","doi-asserted-by":"crossref","first-page":"2400809","DOI":"10.1002\/adhm.202400809","article-title":"Emerging chemodynamic nanotherapeutics for cancer treatment","volume":"13","author":"Sun","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1445","doi-asserted-by":"crossref","first-page":"2100243","DOI":"10.1002\/adfm.202100243","article-title":"Recent advances in nanomaterial-based nanoplatforms for chemodynamic cancer therapy","volume":"31","author":"Li","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1450","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202502028","article-title":"Fe-doped carbon dots control the biodegradation behaviors of Zr-based metal\u2013organic framework for tumor-specific chemotherapy and ferroptosis enhanced sono-chemodynamic therapy","volume":"21","author":"Shi","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114915_bb1455","doi-asserted-by":"crossref","first-page":"1027124","DOI":"10.3389\/fimmu.2022.1027124","article-title":"Advancing immune checkpoint blockade in colorectal cancer therapy with nanotechnology","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1460","doi-asserted-by":"crossref","first-page":"10920","DOI":"10.1021\/acs.chemrev.3c00062","article-title":"Tumor abnormality-oriented nanomedicine design","volume":"123","author":"Zhou","year":"2023","journal-title":"Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb1465","doi-asserted-by":"crossref","first-page":"5461","DOI":"10.1002\/jcp.29494","article-title":"PD-1\/PD-L1-dependent immune response in colorectal cancer","volume":"235","author":"Payandeh","year":"2020","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1470","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s13046-021-01987-7","article-title":"Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer","volume":"40","author":"Zhang","year":"2021","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1475","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jconrel.2020.06.017","article-title":"Blockade of CTLA-4 increases anti-tumor response inducing potential of dendritic cell vaccine","volume":"326","author":"Esmaily","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114915_bb1480","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13046-019-1259-z","article-title":"Combination of CTLA-4 and PD-1 blockers for treatment of cancer","volume":"38","author":"Rotte","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1485","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygeno.2023.110646","article-title":"Exosomes-delivered PD-L1 siRNA and CTLA-4 siRNA protect against growth and tumor immune escape in colorectal cancer","volume":"115","author":"Li","year":"2023","journal-title":"Genomics"},{"key":"10.1016\/j.jconrel.2026.114915_bb1490","first-page":"2183","article-title":"CAR T cell therapy: a new era for cancer treatment","volume":"42","author":"Mohanty","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.jconrel.2026.114915_bb1495","doi-asserted-by":"crossref","first-page":"2004713","DOI":"10.1002\/adfm.202004713","article-title":"Nanotechnology-based CAR-T strategies for improving efficacy and safety of tumor immunotherapy","volume":"31","author":"Wang","year":"2021","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1500","doi-asserted-by":"crossref","first-page":"2304615","DOI":"10.1002\/adhm.202304615","article-title":"Nanomaterials boost CAR-T therapy for solid tumors","volume":"13","author":"Long","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1505","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1158\/1538-7445.AM2025-1811","article-title":"Use of lipid nanoparticles to generate CAR T cells targeting colon cancer","volume":"85","author":"Goulart Guimaraes","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1510","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101985","article-title":"Investigation of the enhanced antitumour potency of CD46-specific chimeric antigen receptor-T cells in human colorectal cancer liver metastases after combination with nanotherapeutics","volume":"52","author":"Meng","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.114915_bb1515","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.tips.2024.03.004","article-title":"Direct in vivo CAR T cell engineering","volume":"45","author":"Short","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb1520","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev-bioeng-070620-033348","article-title":"In situ programming of CAR T cells","volume":"23","author":"Parayath","year":"2021","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2026.114915_bb1525","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011759","article-title":"T cell-specific non-viral DNA delivery and in vivo CAR-T generation using targeted lipid nanoparticles","volume":"13","author":"Bimbo","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb1530","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s12032-025-02928-6","article-title":"Applications of nanoparticles in CAR-T cell therapy: non-viral manufacturing, enhancing in vivo function, and in vivo generation of CAR-T cells","volume":"42","author":"Albalawi","year":"2025","journal-title":"Med. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1535","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/s41577-025-01174-1","article-title":"In vivo CAR engineering for immunotherapy","volume":"25","author":"Li","year":"2025","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1540","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.gendis.2022.07.009","article-title":"Functional crosstalk and regulation of natural killer cells in tumor microenvironment: significance and potential therapeutic strategies","volume":"10","author":"Wang","year":"2023","journal-title":"Genes Dis."},{"key":"10.1016\/j.jconrel.2026.114915_bb1545","doi-asserted-by":"crossref","first-page":"5438","DOI":"10.3390\/cancers14215438","article-title":"Nanoparticle enhancement of natural killer (NK) cell-based immunotherapy","volume":"14","author":"Murugan","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.jconrel.2026.114915_bb1550","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1555","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1021\/acsbiomaterials.4c01725","article-title":"Nanomaterial-interleukin combination for boosting NK cell-based tumor immunotherapy","volume":"11","author":"Guo","year":"2025","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.jconrel.2026.114915_bb1560","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41416-018-0328-y","article-title":"Cytokines in clinical cancer immunotherapy","volume":"120","author":"Berraondo","year":"2019","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb1565","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.nano.2017.04.006","article-title":"Modified nanoparticle mediated IL-12 immunogene therapy for colon cancer","volume":"13","author":"Liu","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.jconrel.2026.114915_bb1570","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.7150\/thno.24157","article-title":"Powerful anti-colon cancer effect of modified nanoparticle-mediated IL-15 immunogene therapy through activation of the host immune system","volume":"8","author":"Liu","year":"2018","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2026.114915_bb1575","doi-asserted-by":"crossref","first-page":"32431","DOI":"10.1021\/jacs.4c08327","article-title":"Nanoenabled IL-15 Superagonist via Conditionally Stabilized Protein\u2013Protein Interactions Eradicates Solid Tumors by Precise Immunomodulation","volume":"146","author":"Chen","year":"2024","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2026.114915_bb1580","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1021\/acs.molpharmaceut.0c00451","article-title":"Efficient colorectal cancer gene therapy with IL-15 mRNA nanoformulation","volume":"17","author":"Lei","year":"2020","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.jconrel.2026.114915_bb1585","doi-asserted-by":"crossref","DOI":"10.1016\/j.ntm.2025.100092","article-title":"Tumor microenvironment-responsive nanoplatforms for enhanced cancer immunotherapy: advances and synergistic strategies","volume":"4","author":"Wu","year":"2025","journal-title":"Nano TransMed."},{"key":"10.1016\/j.jconrel.2026.114915_bb1590","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/s12951-022-01476-9","article-title":"Nanoparticles mediated tumor microenvironment modulation: current advances and applications","volume":"20","author":"Raju","year":"2022","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1595","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canlet.2021.08.019","article-title":"Multifunctional biomaterials that modulate oxygen levels in the tumor microenvironment","volume":"521","author":"Hu","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb1600","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s12951-024-03060-9","article-title":"Therapeutic delivery of oxygen using artificial oxygen carriers demonstrates the possibility of treating a wide range of diseases","volume":"23","author":"Mohanto","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1605","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.174675","article-title":"Oxygen-carrying nanoemulsions and respiratory hyperoxia eliminate tumor hypoxia\u2013induced immunosuppression","volume":"10","author":"Halpin-Veszeleiova","year":"2025","journal-title":"JCI Insight"},{"key":"10.1016\/j.jconrel.2026.114915_bb1610","doi-asserted-by":"crossref","first-page":"1115254","DOI":"10.3389\/fbioe.2023.1115254","article-title":"Perfluorocarbons: a perspective of theranostic applications and challenges","volume":"11","author":"Kakaei","year":"2023","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1615","doi-asserted-by":"crossref","first-page":"2406860","DOI":"10.1002\/smll.202406860","article-title":"Dual oxygen-supply immunosuppression-inhibiting nanomedicine to avoid the intratumoral recruitment of myeloid-derived suppressor cells","volume":"20","author":"Yang","year":"2024","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114915_bb1620","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1186\/s12951-024-02606-1","article-title":"Nanomaterial-related hemoglobin-based oxygen carriers, with emphasis on liposome and nano-capsules, for biomedical applications: current status and future perspectives","volume":"22","author":"Zhu","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1625","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1021\/acsmaterialslett.3c01158","article-title":"Oxygen-enriched MOF-hemoglobin X-ray nanosensitizer for enhanced cancer radio\u2013radiodynamic therapy","volume":"5","author":"Zhao","year":"2023","journal-title":"ACS Mater. Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb1630","doi-asserted-by":"crossref","first-page":"20875","DOI":"10.1021\/acsnano.3c07763","article-title":"Nanomedicine strategies in conquering and utilizing the cancer hypoxia environment","volume":"17","author":"Pan","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1635","doi-asserted-by":"crossref","first-page":"33835","DOI":"10.1039\/D2RA06036A","article-title":"Smart biomaterials for enhancing cancer therapy by overcoming tumor hypoxia: a review","volume":"12","author":"Salim","year":"2022","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2026.114915_bb1640","doi-asserted-by":"crossref","first-page":"11283","DOI":"10.1039\/D4RA08547G","article-title":"Manganese-based nanoparticles plus gambogic acid targeted hypoxic tumor microenvironment by enhancing ROS generation and provided antitumor treatment and improved immunotherapy","volume":"15","author":"Liang","year":"2025","journal-title":"RSC Adv."},{"key":"10.1016\/j.jconrel.2026.114915_bb1645","article-title":"Catalase-like nanozymes: classification, catalytic mechanisms, and their applications","volume":"18","author":"Xu","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114915_bb1650","article-title":"A novel \u201cthree-in-one\u201d copper-based metal-organic framework nanozyme eradicates colorectal cancer and overcomes chemoresistance for tumor therapy","volume":"12","author":"Dong","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb1655","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.164764","article-title":"Surface engineering of copper peroxide nanodots and Au nanozyme on porphyrin-based metal-organic frameworks induces cascade reactions for colorectal cancer treatment","volume":"518","author":"Chen","year":"2025","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.114915_bb1660","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12951-025-03217-0","article-title":"Regulation of cancer-associated fibroblasts for enhanced cancer immunotherapy using advanced functional nanomedicines: an updated review","volume":"23","author":"Liao","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1665","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/s41573-018-0004-1","article-title":"Turning foes to friends: targeting cancer-associated fibroblasts","volume":"18","author":"Chen","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2026.114915_bb1670","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217475","article-title":"FAP upregulates PD-L1 expression in cancer-associated fibroblasts to exacerbate t cells dysfunction and suppress anti-tumor immunity","volume":"612","author":"Wei","year":"2025","journal-title":"Cancer Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb1675","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1039\/D2TB02253B","article-title":"Cancer-associated fibroblast-targeted nanodrugs reshape colorectal tumor microenvironments to suppress tumor proliferation, metastasis and improve drug penetration","volume":"11","author":"Shen","year":"2023","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.jconrel.2026.114915_bb1680","doi-asserted-by":"crossref","first-page":"2100164","DOI":"10.1002\/sstr.202100164","article-title":"Modulation of tumor vasculature network: key strategies","volume":"3","author":"Taleb","year":"2022","journal-title":"Small Struct."},{"key":"10.1016\/j.jconrel.2026.114915_bb1685","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jconrel.2022.07.015","article-title":"Anti-angiogenic nano-delivery system promotes tumor vascular normalizing and micro-environment reprogramming in solid tumor","volume":"349","author":"Shen","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114915_bb1690","doi-asserted-by":"crossref","first-page":"8674","DOI":"10.1021\/acs.nanolett.3c02514","article-title":"Molecularly imprinted nanomedicine for anti-angiogenic cancer therapy via blocking vascular endothelial growth factor signaling","volume":"23","author":"Zhao","year":"2023","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2026.114915_bb1695","first-page":"2354","article-title":"Enhancing bevacizumab efficacy in a colorectal tumor mice model using dextran-coated albumin nanoparticles, drug delivery","volume":"15","author":"Pangua","year":"2025","journal-title":"Transl. Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1700","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1002\/jcp.26051","article-title":"Combination of nanotechnology with vascular targeting agents for effective cancer therapy","volume":"233","author":"Jahanban-Esfahlan","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1705","doi-asserted-by":"crossref","first-page":"23746","DOI":"10.1021\/acsnano.5c03638","article-title":"Combretastatin A4-based albumin nanoparticles remodeling the tumor immune microenvironment to enhance T cell immunotherapy in colon cancer","volume":"19","author":"Wang","year":"2025","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1710","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.phrs.2016.08.026","article-title":"Regulation and role of endogenously produced hydrogen sulfide in angiogenesis","volume":"113","author":"Katsouda","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1715","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jconrel.2023.02.028","article-title":"Colon-targeted bacterial hydrogel for tumor vascular normalization and improved chemotherapy","volume":"356","author":"Li","year":"2023","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114915_bb1720","doi-asserted-by":"crossref","DOI":"10.1038\/s41522-025-00818-3","article-title":"Harnessing gut microbiota for colorectal cancer therapy: from clinical insights to therapeutic innovations","volume":"11","author":"Chen","year":"2025","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.jconrel.2026.114915_bb1725","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/s41565-019-0589-5","article-title":"Nanotechnology intervention of the microbiome for cancer therapy","volume":"14","author":"Song","year":"2019","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1730","article-title":"Novel therapeutic strategies and recent advances in gut microbiota synergy with nanotechnology for colorectal cancer treatment","volume":"31","author":"Han","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.jconrel.2026.114915_bb1735","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.213","article-title":"The challenge and opportunity of gut microbiota-targeted nanomedicine for colorectal cancer therapy","volume":"3","author":"Wei","year":"2024","journal-title":"Imeta"},{"key":"10.1016\/j.jconrel.2026.114915_bb1740","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1158\/1078-0432.CCR-13-1343","article-title":"Colonization of the human gut by E. coli and colorectal cancer risk","volume":"20","author":"Bonnet","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2026.114915_bb1745","doi-asserted-by":"crossref","first-page":"2306281","DOI":"10.1002\/adma.202306281","article-title":"Antibacterial Fusobacterium nucleatum-mimicking nanomedicine to selectively eliminate tumor-colonized bacteria and enhance immunotherapy against colorectal cancer","volume":"35","author":"Chen","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1750","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2023.141982","article-title":"The colorectal cancer-specific microbiome regulation and immune response activation via an artificial biomimetic nanovaccine","volume":"461","author":"Zhuang","year":"2023","journal-title":"Chem. Eng. J."},{"key":"10.1016\/j.jconrel.2026.114915_bb1755","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/s41587-023-01957-8","article-title":"Killing tumor-associated bacteria with a liposomal antibiotic generates neoantigens that induce anti-tumor immune responses","volume":"42","author":"Wang","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1760","doi-asserted-by":"crossref","first-page":"2304257","DOI":"10.1002\/adma.202304257","article-title":"Engineering clinically relevant probiotics with switchable \u201cnano-promoter\u201d and \u201cnano-effector\u201d for precision tumor therapy","volume":"36","author":"Cao","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1765","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1038\/s41467-023-40439-y","article-title":"Combining gut microbiota modulation and chemotherapy by capecitabine-loaded prebiotic nanoparticle improves colorectal cancer therapy","volume":"14","author":"Lang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2026.114915_bb1770","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202403587","article-title":"5-Fluorouracil loaded prebiotic\u2013probiotic liposomes modulating gut microbiota for improving colorectal cancer chemotherapy","volume":"14","author":"Sun","year":"2025","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1775","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.actbio.2021.07.051","article-title":"Photothermal therapy mediated by gold nanocages composed of anti-PDL1 and galunisertib for improved synergistic immunotherapy in colorectal cancer","volume":"134","author":"Wang","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.jconrel.2026.114915_bb1780","doi-asserted-by":"crossref","first-page":"7371","DOI":"10.3390\/ijms22147371","article-title":"CXCL12-CXCR4\/CXCR7 axis in colorectal cancer: therapeutic target in preclinical and clinical studies","volume":"22","author":"Khare","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb1785","doi-asserted-by":"crossref","DOI":"10.1016\/j.nantod.2023.101992","article-title":"Gene-activating nanomedicine for the tumor-oriented infiltration of T cells to enhance immunotherapy against solid tumors","volume":"52","author":"Zhang","year":"2023","journal-title":"Nano Today"},{"key":"10.1016\/j.jconrel.2026.114915_bb1790","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1186\/s12951-024-02701-3","article-title":"Inorganic nanoparticle-based treatment approaches for colorectal cancer: recent advancements and challenges","volume":"22","author":"Narayana","year":"2024","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1795","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb1800","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.3390\/pharmaceutics14081541","article-title":"Recent advances in CXCL12\/CXCR4 antagonists and nano-based drug delivery systems for cancer therapy","volume":"14","author":"Zhao","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.jconrel.2026.114915_bb1805","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202500225","article-title":"Nanoparticle-mediated CXCL12\u2013CXCR4 inhibition reprograms macrophages and suppresses gastric carcinoma","volume":"12","author":"Cao","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.jconrel.2026.114915_bb1810","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12943-025-02496-3","article-title":"The enhanced cancer nanovaccine by bidirectionally blocking CXCL12\/CXCR4 axis to inhibit the recurrence and metastasis of triple-negative breast cancer","volume":"24","author":"Liu","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb1815","doi-asserted-by":"crossref","first-page":"e15566","DOI":"10.1200\/JCO.2025.43.16_suppl.e15566","article-title":"Phase II study of irinotecan liposome combined with 5-FU\/LV + bevacizumab as first-line therapy in metastatic colorectal cancer: An early analysis from the study","volume":"43","author":"Qiu","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1820","doi-asserted-by":"crossref","DOI":"10.1016\/j.ccr.2024.216381","article-title":"Metal-organic frameworks (MOFs) for phototherapy and synergistic phototherapy of cancer","volume":"526","author":"Tong","year":"2025","journal-title":"Coord. Chem. Rev."},{"key":"10.1016\/j.jconrel.2026.114915_bb1825","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mattod.2023.03.006","article-title":"Hydrogel-enabled, local administration and combinatorial delivery of immunotherapies for cancer treatment","volume":"65","author":"Erfani","year":"2023","journal-title":"Mater. Today"},{"key":"10.1016\/j.jconrel.2026.114915_bb1830","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1038\/s41590-024-02015-4","article-title":"Next-generation combination approaches for immune checkpoint therapy","volume":"25","author":"Goswami","year":"2024","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2026.114915_bb1835","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.551","article-title":"New insights into immune cells in cancer immunotherapy: from epigenetic modification, metabolic modulation to cell communication","volume":"5","author":"Qin","year":"2024","journal-title":"MedComm"},{"key":"10.1016\/j.jconrel.2026.114915_bb1840","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1186\/s12943-021-01464-x","article-title":"Epigenetic modulation of antitumor immunity for improved cancer immunotherapy","volume":"20","author":"Dai","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jconrel.2026.114915_bb1845","doi-asserted-by":"crossref","first-page":"eadr6049","DOI":"10.1126\/scitranslmed.adr6049","article-title":"Generating functionally stable and antigen-specific Treg cells from effector T cells for cell therapy of inflammatory diseases","volume":"17","author":"Mikami","year":"2025","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.jconrel.2026.114915_bb1850","doi-asserted-by":"crossref","first-page":"113782","DOI":"10.1016\/j.jconrel.2025.113782","article-title":"Smart on-demand drug release strategies for cancer combination therapy","volume":"383","author":"Huang","year":"2025","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2026.114915_bb1855","doi-asserted-by":"crossref","DOI":"10.1002\/smll.202507577","article-title":"Advances in multicompartment synthetic protocells: from design strategies to biomedical application","volume":"21","author":"Kou","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2026.114915_bb1860","doi-asserted-by":"crossref","first-page":"31421","DOI":"10.1021\/acsnano.4c11334","article-title":"Triggered cascade-activation nanoplatform to alleviate hypoxia for effective tumor immunotherapy guided by NIR-II imaging","volume":"18","author":"Ji","year":"2024","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2026.114915_bb1865","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.7150\/thno.108875","article-title":"Macrophage membrane-functionalized nanotherapeutics for tumor targeted therapy","volume":"15","author":"Khan","year":"2025","journal-title":"Theranostics"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365926003172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:07:53Z","timestamp":1793945273000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365926003172"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":373,"alternative-id":["S0168365926003172"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114915","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine for colorectal cancer therapy by remodeling the immune microenvironment","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2026.114915","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"114915"}}